Sleeve lobectomy versus pneumonectomy following neoadjuvant therapy in patients with non-small cell lung cancer
SL stands as a safe and feasible option for patients with centrally located non-small-cell lung cancer who have undergone neoadjuvant therapy, in comparison to PN. This finding suggests that SL remains the preferable choice when feasible in the context of the widespread utilization of neoadjuvant therapy.
Authors
- Shuyu Ji
- Chengxiang Yi (ORCID: https://orcid.org/0000-0002-9045-7236)
- Ziyun Shen (ORCID: https://orcid.org/0000-0001-5013-8532)
- Weiguang Yang (ORCID: https://orcid.org/0000-0002-9862-5839)
- Wangchao Yao (ORCID: https://orcid.org/0009-0007-8386-1146)
- Jing Zhang (ORCID: https://orcid.org/0000-0001-6241-5330)
- Peng Zhang (ORCID: https://orcid.org/0000-0003-1771-7545)
- Shiqi Hu (ORCID: https://orcid.org/0000-0001-7394-0931)
- Qing Yang (ORCID: https://orcid.org/0000-0002-9730-0901)
- Meixin Teng
Institutions
- Shihezi University (CN)
- Tongji University (CN)
- Wenzhou Medical University (CN)
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Shanghai Pulmonary Hospital (CN)
Publication Details
- Journal
- European Journal of Cardio-Thoracic Surgery
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1093/ejcts/ezae300
- Citations
- 11
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.61
Funders
- Shanghai Municipal Education Commission
- Science and Technology Commission of Shanghai Municipality
- Chinese Society of Clinical Oncology
- Shanghai Pulmonary Hospital